Sleep in schizophrenia patients and the effects of antipsychotic drugs

Sleep Medicine Reviews

Volumn 8, Issue 2, 2004, Pages 133-148

  Monti, Jaime M ^a   Monti, Daniel ^b  

^a HOSPITAL DE CLÍNICAS   (Uruguay)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Dopamine; Insomnia; Schizophrenia patients; Serotonin; Typical and atypical antipsychotics

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; DOPAMINE; FLUPENTIXOL; HALOPERIDOL; NEUROLEPTIC AGENT; NEUROTRANSMITTER; OLANZAPINE; RISPERIDONE; STAGE 2 SLEEP; STAGE 4 SLEEP; TIOTIXENE; UNCLASSIFIED DRUG;

CLINICAL FEATURE; DISEASE EXACERBATION; DRUG EFFECT; DRUG MECHANISM; HUMAN; INSOMNIA; LATENT PERIOD; NEGATIVE SYNDROME; NEUROIMAGING; NONREM SLEEP; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; RELAPSE; REM SLEEP; REVIEW; SCHIZOPHRENIA; SLEEP; SLEEP DISORDER; SLEEP PATTERN; SLEEP STAGE; SLEEP TIME; SLOW WAVE SLEEP;

EID: 1842481376     PISSN: 10870792     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1087-0792(02)00158-2     Document Type: Review

References (74)

1. American Psychiatric Association, Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Press 1994.
2. Jablensky A, Sartorius N, Ernberg G et al. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl 1992; 20: 1-97.
3. Van Kammen DP, van Kammen WB, Peters JL et al. CSF MHPG sleep and psychosis in schizophrenia. Clin Neuropharmacol 1986; 9(Suppl. 4): 575-577.
4. American Sleep Disorders Association, International classification of sleep disorders, revised: diagnostic and coding manual. Rochester, MN: American Sleep Disorders Association 1997.
5. Carskadon MA, Dement WC. Normal human sleep: an overview. In: MH Kryger, T Roth, WC Dement (eds.) Principles and practice of sleep medicine. Philadelphia: WB Saunders 2000; 15-25. [chapter 2].
6. Ganguli R, Reynolds CF, Kupfer DJ. Electroencephalographic sleep in young, never-medicated schizophrenics. Arch Gen Psychiatry 1987; 44: 36-44.
7. Tandon R, Shipley JE, Taylor S et al. Electroencephalographic sleep abnormalities in schizophrenia. Arch Gen Psychiatry 1992; 49: 185-194.
8. Lauer CJ, Schreiber W, Pollmächer T et al. Sleep in schizophrenia: a polysomnographic study on drug-naive patients. Neuropsychopharmacology 1997; 16: 51-60.
9. Jus K, Bouchard M, Jus AK et al. Sleep EEG studies in untreated, long-term schizophrenic patients. Arch Gen Psychiatry 1973; 29: 386-390.
10. Lauer CJ, Krieg JC. Slow-wave sleep and ventricular size: a comparative study in schizophrenia and major depression. Biol Psychiatry 1998; 44: 121-128.
11. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages in human subjects. NIH Publ 204, Washington, DC: US Government Printing Office 1968.
12. Monti JM. Sleep laboratory and clinical studies of the effects of triazolam, flunitrazepam and flurazepam in insomniac patients. Meth Find Exptl Clin Pharmacol 1981; 3: 303-326.
13. Keshavan MS, Reynolds CF, Miewald JM et al. Delta sleep deficits in schizophrenia. Arch Gen Psychiatry 1998; 55: 443-448.
14. Hudson JI, Lipinski JF, Keck PE et al. Polysomnographic characteristics of schizophrenia in comparison with mania and depression. Biol Psychiatry 1993; 34: 191-193.
15. Benson KL, Sullivan EV, Lim KO et al. Slow wave sleep and computed tomographic measures of brain morphology in schizophrenia. Psychiatry Res 1996; 60: 125-134.
16. Hoffmann R, Hendrickse W, Rush AJ et al. Slow-wave activity during non-REM sleep in men with schizophrenia and major depressive disorders. Psychiatry Res 2000; 95: 215-225.
17. Williams HL, Hammack JT, Daly RT et al. Responses to auditory stimulation, sleep loss, and the EEG stages of sleep. Electroenceph Clin Neurophysiol 1964; 16: 269-275.
18. Dement W, Kleitman N. The relation of eye movements during sleep to dream activity: an objective method for the study of dreaming. J Exp Psychol 1957; 53: 339-346.
19. Feinberg I, Koresko RL, Gottlieb F et al. Sleep electroencephalographic and eye-movement patterns in schizophrenic patients. Compr Psychiatry 1964; 5: 44-53.
20. Feinberg I, Koresko RL, Gottlieb F. Further observations on electrophysiological sleep patterns in schizophrenia. Compr Psychiatry 1965; 6: 21-24.
21. Feinberg I, Braun M, Koresko RL et al. Stage 4 sleep in schizophrenia. Arch Gen Psychiatry 1969; 21: 263-266.
22. Caldwell DF, Domino EF. Electroencephalographic and eye movement patterns during sleep in chronic schizophrenic patients. Electroenceph Clin Neurophysiol 1967; 22: 414-420.
23. Stern M, Fram DH, Wyatt R et al. All-night sleep studies of acute schizophrenics. Arch Gen Psychiatry 1969; 20: 470-477.
24. Hiatt JF, Floyd TC, Katz PH et al. Further evidence of abnormal non-rapid-eye-movement sleep in schizophrenia. Arch Gen Psychiatry 1985; 42: 797-802.
25. Zarcone VP, Benson KL, Berger PA. Abnormal rapid eye movement latencies in schizophrenia. Arch Gen Psychiatry 1987; 44: 45-48.
26. Kempenaers C, Kerkhofs M, Linkowski P et al. Sleep EEG variables in young schizophrenic and depressive patients. Biol Psychiatry 1988; 24: 833-838.
27. Benson KL, Faull KF, Zarcone VP. Evidence for the role of serotonin in the regulation of slow wave sleep in schizophrenia. Sleep 1991; 14: 133-139.
28. Benson KL, Zarcone VP. Rapid eye movement sleep eye movements in schizophrenia and depression. Arch Gen Psychiatry 1993; 50: 474-482.
29. Brannen JO, Jewett RE. Effects of selected phenothiazines on REM sleep in schizophrenics. Arch Gen Psychiatry 1969; 21: 284-290.
30. Gillin C, Buchsbaum MS, Jacobs LS et al. Partial REM sleep deprivation, schizophrenia and field articulation. Arch Gen Psychiatry 1974; 30: 653-662.
31. Reich L, Weiss BL, Coble P et al. Sleep disturbance in schizophrenia. Arch Gen Psychiatry 1975; 32: 51-55.
32. Brambilla F, Scarone S, Pugnetti L et al. Bromocriptine therapy in chronic schizophrenia: effects of symptomatology, sleep patterns, and prolactine response to stimulation. Psychiatry Res 1983; 8: 159-169.
33. van Kammen DP, van Kammen WB, Peters J et al. Decreased slow-wave sleep and enlarged lateral ventricles in schizophrenia. Neuropsychopharmacology 1988; 1: 265-271.
34. Thaker GK, Wagman AMI, Tamminga CA. Sleep polygraphy in schizophrenia: methodological issues. Biol Psychiatry 1990; 28: 240-246.
35. Taylor SF, Tandon R, Shipley JE et al. Sleep onset REM periods in schizophrenic patients. Biol Psychiatry 1991; 30: 205-209.
36. Nofzinger EA, van Kammen DP, Gilbertson MW et al. Electroencephalographic sleep in clinically stable schizophrenic patients: two-weeks versus six-weeks neuroleptic free. Biol Psychiatry 1993; 33: 829-835.
37. Zarcone VP, Benson KL. BPRS symptom factors and sleep variables in schizophrenia. Psychiatry Res 1997; 66: 111-120.
38. Monti JM, Altier H. Flunitrazepam (RO 5-4200) and sleep in normal subjects. Psychopharmacologia 1973; 32: 343-349.
39. Keshavan MS, Miewald J, Haas G et al. Slow-wave sleep and symptomatology in schizophrenia and related psychotic disorders. J Psychiat Res 1995; 29: 303-314.
40. Kajimura N, Kato M, Okuma T et al. Relationship between delta activity during all-night sleep and negative symptoms in schizophrenia: a preliminary study. Biol Psychiatry 1996; 39: 451-454.
41. Baldessarini RJ. Drugs for the treatment of psychiatric disorders. In: JG Hardman, LE Limbird (eds.) The pharmacological basis of therapeutics. New York: McGraw-Hill 1996; 399-459. [chapter 18].
42. Carlsson A, Lindquist M. Effects of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 1963; 20: 140-144.
43. Verhoeff NP. Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders. Psychopharmacology 1999; 147: 217-249.
44. Laruelle M, Abi-Dargham A, van Dyck CH et al. Single photon emission computarized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 1996; 93: 9235-9240.
45. Breier A, Su TP, Saunders R et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission topography method. Proc Natl Acad Sci USA 1997; 94: 2569-2574.
46. Abi-Dargham A, Gil R, Krystal J et al. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry 1998; 155: 761-767.
47. Monti JM, Hawkins M, Jantos H et al. Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat. Psychopharmacology 1988; 95: 395-400.
48. Monti JM, Jantos H, Fernández M. Effects of the dopamine D2 receptor agonist, quinpirole on sleep and wakefulness in the rat. Eur J Pharmacol 1989; 169: 61-66.
49. Dursun SM, Patel JKM, Burke JG et al. Effects of typical antipsychotic drugs and risperidone on the quality of sleep in patients with schizophrenia: a pilot study. J Psychiatry Neurosci 1999; 24: 333-337.
50. Sharpley AL, Vassallo CM, Cowen PJ. Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT2C receptors in vivo. Biol Psychiatry 2000; 47: 468-470.
51. Sharpley AL, Vassallo CM, Pooley EC et al. Allelic variation in the 5-HT2C receptor (HT2RC) and the increase in slow wave sleep produced by olanzapine. Psychopharmacology 2001; 153: 271-272.
52. Haffmans PMJ, Oolders JM, Hoencamp E et al. The effect of risperidone versus haloperidol on sleep patterns of schizophrenic patients: results of a double-blind, randomised pilot trial. Eur Neuropsychopharm 2001; 11 (Suppl. 3): S260.
53. Bixler EO, Vgontzas AN, Kales A. Methodological issues in pharmacological studies of sleep. In: A Kales (ed.) The pharmacology of sleep. Berlin: Springer 1995; 323-343. [chapter 12].
54. Taylor SF, Tandon R, Shipley JE et al. Effect of neuroleptic treatment on polysomnographic measures in schizophrenia. Biol Psychiatry 1991; 30: 904-912.
55. Wetter TC, Lauer CJ, Gillich G et al. The electroencephalographic sleep pattern in schizophrenic patients treated with clozapine or classical antipsychotic drugs. J psychiat Res 1996; 30: 411-419.
56. Salin-Pascual RJ, Herrera-Estrella M, Galicia-Polo L et al. Olanzapine acute administration in schizophrenic patients increases delta sleep and sleep efficiency. Biol Psychiatry 1999; 46: 141-143.
57. Maixner S, Tandon R, Eiser A et al. Effects of antipsychotic treatment on polysomnographic measures in schizophrenia: a replication and extension. Am J Psychiatry 1998; 155: 1600-1602.
58. Yamashita H, Morinobu S, Yamakawi S et al. Effect of risperidone on sleep in schizophrenia: a comparison with haloperidol. Psychiatry Res 2002; 109: 137-142.
59. Touyz SW, Saayman GS, Zabow T. A psychophysiological investigation of the long-term effects of clozapine upon sleep patterns of normal young adults. Psychopharmacology 1978; 56: 69-73.
60. Staedt J, Stoppe G, Hajak G et al. Rebound insomnia after abrupt clozapine withdrawal. Eur Arch Psychiatry Clin Neurosci 1996; 246: 79-82.
61. Blin O. A comparative review of new antipsychotics. Can J Psychiatry 1999; 44: 235-244.
62. Horácek J. Novel antipsychotics and extrapyramidal side effects. Theory and reality. Pharmacopsychiatry 2000; 33: 34-42.
63. Stip E. Novel antipsychotics: issues and controversies. Typical and atypical antipsychotics. J Psychiatry Neurosci 2000; 25: 137-153.
64. Kapur S, Remington G. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. Annu Rev Med 2001; 52: 503-517.
65. Monti JM. Disturbances of sleep and wakefulness associated with the use of antihypertensive agents. Life Sci 1987; 41: 1979-1988.
66. Heller-Brown J, Tylor P. Muscarinic receptor agonists and antagonists. In: JG Hardman, LE Limbird (eds.) The pharmacological basis of therapeutics. New York: McGraw-Hill 1996; 141-160. [chapter 7].
67. Monti JM, Monti D. Histamine H1 receptor antagonists in the treatment of insomnia. Is there a rational basis for use? CNS Drugs 2000; 13: 87-96.
68. Idzikowski C, Mills FJ, Glennard R. 5-Hydroxytryptamine-2-antagonist increases human slow wave sleep. Brain Res 1986; 378: 164-168.
69. Idzikowski C, Cowen PJ, Nutt D et al. The effects of chronic ritanserin treatment on sleep and the neuroendocrine response to L-tryptophan. Psychopharmacology 1987; 93: 416-420.
70. Adam K, Oswald I. Effects of repeated ritanserin on middle-aged poor sleepers. Psychopharmacology 1989; 99: 219-221.
71. Ruiz-Primo E, Haro R, Valencia M. Polysomnographic effects of ritanserin in insomniacs: a crossed double-blind controlled study. Sleep Res 1989; 18: 72.
72. Katsuda Y, Walsh AES, Ware CJ et al. meta-Chlorophenylpiperazine decreased slow wave sleep in humans. Biol Psychiatry 1993; 33: 49-51.
73. Sharpley AL, Elliot JM, Attenburrow MJ et al. Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors. Neuropharmacology 1994; 33: 467-471.
74. Hinze-Setch D, Mullington J, Orth A et al. Effects of clozapine on sleep: a longitudinal study. Biol Psychiatry 1997; 42: 260-266.